Thank you for visiting the BIG Hospital SBIRT Initiative led by NORC at the University of Chicago and the National SBIRT ATTC (N SBIRT ATTC). Funded by SAMHSA, the National SBIRT ATTC (N SBIRT ATTC) is housed at the Institute for Research, Education and Training in Addictions (IRETA) in Pittsburgh, PA. Together IRETA and NORC as the N SBIRT ATTC:
Of the 2.5 million patients admitted annually with substance use disorders, fewer than half are asked about their substance use, according to NIH. Less than 1 in 20 of the 1.5 million patients admitted for trauma caused by risky substance use have any medical notation that substance use was assessed. Hospitals miss many opportunities to treat patients for these very treatable illnesses. Clinicians receive little training about substance use assessment or treatment in medical school or later; they are not trained in brief intervention techniques; and are often unaware of community treatment resources. Medical and hospital billing departments are unfamiliar with the new SBI billing codes, limiting reimbursement for services. If the Joint Commission today were to mandate the nation’s 5,012 hospitals to routinely screen and treat patients’ substance use problems, few could comply. But, if done, SBI can cut reinjury and rehospitalization in half, and save billions of treatment dollars.
Screening and Brief Intervention (SBI) is a well researched practice that has demonstrated consistent success in correctly identifying alcohol needs in patients and assisting them to reduce hazardous use. SBI is not widely or consistently used in the medical field. Not yet.
By working together to prepare hospitals to provide routine screening and brief counseling for substance use, we can change practice in hospitals and practitioners’ adherence to evidenced-based SBI protocols.
This website outlines the Hospital SBI Initiative and provides a brief overview of SBI. This project is a two-year action campaign to prepare the nation’s hospitals to screen, prevent and treat the unhealthy alcohol, drug and tobacco use of patients.
We invite your participation in this exciting new movement in the field. Click here to get involved!
Eric Goplerud, PhD - Goplerudemail@example.com
Larry Gentilello, MD - firstname.lastname@example.org